Bath & Body Works Inc. (NYSE:) shares were trading more than 5% lower after-hours despite the company’s Q1 EPS of $0.64 coming in better than the consensus estimate of $0.50.

Year-over-year, revenue declined by 1% to $1.45billion. This beats the consensus estimate at $1.38billion. Revenue increased 2% year-overyear, exempting $50 million in Q1/21 benefits related to government stimulus payments.

For Q2, the company anticipates diluted EPS to be $0.60-$0.65. It expects 2022-year dilutedEPS to be between $0.60 and $0.65. This is less than its prior guidance of $4.30-$4.70.

Shares of Bath & Body Works were down 39% year-to-date going into the results.

By Davit Kirakosyan